PointState Capital’s Medtronic MDT Stock Holding History

PointState Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-35,000	Closed	-$3.62M	–	105
2021 Q4	$3.62M	Sell	35,000 -5,000	-13%	-$579K	0.06%	98
2021 Q3	$5.01M	Sell	40,000 -7,000	-15%	-$906K	0.08%	102
2021 Q2	$5.83M	Sell	47,000 -67,700	-59%	-$8.5M	0.1%	90
2021 Q1	$13.6M	Buy	114,700 +65,400	+133%	+$7.66M	0.27%	69
2020 Q4	$5.78M	Sell	49,300 -5,700	-10%	-$627K	0.11%	88
2020 Q3	$5.72M	Buy	+55,000	New	+$5.52M	0.15%	66
2015 Q3	–	Sell	-200,000	Closed	-$14.8M	–	124
2015 Q2	$14.8M	Buy	+200,000	New	+$15.3M	0.17%	78

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PointState Capital's MDT Position: Q1 2022 in Review

PointState Capital sold out of Medtronic (MDT) in Q1 2022, closing a stake of 35,000 shares — an estimated $3.62M sold.

PointState Capital first reported a position in MDT in Q2 2015 and held it in 7 quarters. The position peaked at $14.8M in Q2 2015. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

PointState Capital reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
PointState Capital sold 35,000 Medtronic shares in Q1 2022, an estimated $3.62M.
PointState Capital first reported a position in Medtronic in Q2 2015 and held it in 7 quarters.
PointState Capital's Medtronic position peaked at $14.8M in Q2 2015.
2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on PointState Capital's 13F filing for Q1 2022, filed 13 May 2022.